Shukra Pharmaceuticals Fixes Sept 21 as Record Date for Final Dividend
Shukra Pharmaceuticals has set September 21, 2026, as the Record Date for its final dividend of ₹0.01 per equity share for FY 2025-26. The dividend is subject to approval at the 33rd AGM on September 28, 2026.
The dividend amount is nominal (₹0.01 per share), and the fixation of a record date is a standard procedural step for dividend distribution, thus having a minimal impact on the company's stock or operations.
The announcement pertains to the fixation of a record date for a final dividend, which is a routine corporate action and does not inherently indicate a positive or negative shift in the company's performance.
Shukra Pharmaceuticals Limited has announced that Monday, September 21, 2026, has been fixed as the Record Date for determining the eligibility of shareholders to receive the Final Dividend. The proposed dividend is ₹0.01 per equity share of face value ₹1 each for the financial year ended March 31, 2026.
This Final Dividend is subject to the declaration by the company's members at the upcoming 33rd Annual General Meeting (AGM), which is scheduled to be held on Monday, September 28, 2026. Upon declaration, the dividend will be paid to those members whose names appear in the company's Register of Members or in the records of the Depositories as of the Record Date.
The company has fixed the Record Date in compliance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, after providing the requisite advance notice to the Stock Exchanges.
A plain-language summary of a public exchange filing by Shukra Pharmaceuticals Limited. Read the original for the full detail.
